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Otterbein University, Westerville, Ohio
Signs and Symptoms

Introduction
Illicit drug abuse amongst youth and adults
in the United States continues to rise. In
2014, the U.S. had the highest rate of
deaths due to drug overdose (Centers for
Disease Control and Prevention, 2015).
One common way people abuse drugs
today are intravenously (IV), this route
works fast and can cause an “immediate
high”. These drugs are often drawn up in a
syringe and then injected into a vein.
People often inject heroin, cocaine,
prescription opiates and several other
illegal drugs. Needles are often shared
amongst others, or re-used, leading to
increased exposure to infectious diseases.
The use of IV drugs can lead to serious
health issues such as: cellulitis, hepatitis,
HIV, sepsis, abscesses, pulmonary emboli,
and many other conditions. Infective
endocarditis is a disease commonly related
to IV drug abuse, and is often seen on this
nurse’s unit. Infective endocarditis occurs
when bacteria or fungi enters the blood
stream and often infects an individual’s
heart valves (Peirce, Calkins, Thornton,
2012). Infective endocarditis can be lifethreatening and requires aggressive
medical treatment. Treatment often
includes long term antibiotics, frequent
blood monitoring, drug cessation and
sometimes heart valve surgery. After
treatment these patients have to really
consider making lifestyle changes to
improve their health and overall quality of
life.

IE may be classified as acute, sub-acute
or chronic (McCance & Heuther, 2014).
Diagnosis may be difficult due to
clinical manifestations that correspond
with multiple organ systems: CNS,
bones, joints, renal, pulmonary, or eyes
(McCance & Huether, 2014).
•

Night sweats

•

Cardiac murmur

•

Petechial lesions (skin,

While injecting drugs intravenously bacteria can enter the bloodstream and microorganisms
can travel to the heart (McCance & Huether, 2014). Endothelial damage may cause a release of
cytokines, adhesion molecules are then expressed and tissue factor activity rises, resulting in
bacterial adhesions (Evans & Gammie). Bacterial adhesions on the valve cause an inflammatory
response where monocytes react to the release of cytokines which then leads to ulceration,
destruction of tissue, and fibrotic scarring within the valve (Evans & Gammie, 2011). The tissue
then begins repairing itself excessively, causing vegetation to the heart valves (Evans & Gammie,
2011). The coagulation cascade is activated by tissue factor and platelets are then attracted,
which is an element to vegetation (Evans & Gammie, 2011). As the vegetation increases, bacteria
continuously binds and proliferates within the valve (Evans & Gammie, 2011).

conjunctiva, oral mucosa)
•

Osler nodes
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Weight loss
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Chest pain
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Patients diagnosed with IE are often
hospitalized for close management during the
initial treatment process. Nurses have a vital
role in caring for these patients while in the
hospital, rehab facilities, and even in the
home setting. Below lists a few nursing
implications:
•
•
•
•
•

Monitoring vital signs
Administration of antibiotics (IV/PO)
Post-operative care (if surgery
indicated)
Encourage drug cessation, lifestyle
modifications
Education

Conclusion

Frequent Drugs
Injected
•

Implications of Nursing
Care

Pathophysiology

Figure 2. (Habib et al., 2010)

Significance of Pathophysiology
IE is a serious medical condition and can be life threatening. Although there have been
medical advancements, the morbidity and mortality rates of IE are still high (Sabe, Shrestha,
Menon, 2013). Treatment of IE may include long term use of IV antibiotics for several weeks.
If the heart valves are severely damaged, the valve may need to be replaced via open heart
surgery.IE can result from several conditions other than IVDA. Other causative factors may
include: congenital lesions, acquired valve disease, implants (pacemakers, defective valves),
heart transplant, long term indwelling intravenous catheters, or dental procedures (McCance
& Heuther, 2014). Different pathogenesis may occur with each condition. The causative
factors mentioned above may not all be 100% preventable, however, IE caused by IVDA is
100% preventable. IVDA accounts for approximately 9.8 % of the risk factors for IE (Peirce,
Calkins, & Thornton, 2012). Choosing not to abuse drugs would drastically lower ones’ risk of
developing endocarditis.

IE can be a major complication for IVDA. IE often
needs aggressive medical treatment, and
sometime surgical treatment. Individuals who
abuse drugs with IE need to consider lifestyle
modifications to prevent further infections and
promote a healthier life. With the climbing rates
of drug abuse within the U.S. today, we may start
to see a rise in patients with IE and other drug
drug related deaths. As health professionals it is
important for us to continue to encourage drug
cessation, support those trying to quit, and
always educate our community the importance of
not using drugs.

Additional Resources
Agar, J. (2013) Not so safe injection site. Retrieved from
http://www.torontosun.com /2013/07/08/notso-safe-injection-site
Habib, G., Badano, L., Tribouilloy, C., Villacosta, I.,
Zamorano, J.L.,Galderisi, M.,…,Aukhus, S. (2010).
Recommendations for the practice of
echocardiography in infective endocarditis.
Retrieved from http://ehjcimaging .oxford
journals.org /content /11/2/202
Keys, T. (2010). Retrieved from http://www.cleveland
clinicmeded.com /medicalpubs/disease
management/ infectious-disease/infectiveendocarditis/
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